These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells. Ramu A; Cohen L; Glaubiger D Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993 [TBL] [Abstract][Full Text] [Related]
3. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Inaba M; Kobayashi H; Sakurai Y; Johnson RK Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418 [TBL] [Abstract][Full Text] [Related]
4. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy. Yanovich S; Taub RN Cancer Res; 1983 Sep; 43(9):4167-71. PubMed ID: 6871858 [TBL] [Abstract][Full Text] [Related]
5. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines. Hait WN; Pierson NR Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765 [TBL] [Abstract][Full Text] [Related]
7. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Goldenberg GJ; Wang H; Blair GW Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020 [TBL] [Abstract][Full Text] [Related]
8. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells. Mimnaugh EG; Dusre L; Atwell J; Myers CE Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695 [TBL] [Abstract][Full Text] [Related]
9. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells. Ganapathi R; Grabowski D; Rouse W; Riegler F Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165 [TBL] [Abstract][Full Text] [Related]
10. Exploring multidrug resistance using rhodamine 123. Kessel D Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of uptake and cytotoxicity of a low-density lipoprotein-daunomycin complex in P388 leukemic cells. Yanovich S; Preston L; Shaw JM Cancer Res; 1984 Aug; 44(8):3377-82. PubMed ID: 6744272 [TBL] [Abstract][Full Text] [Related]
12. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia. Inaba M; Johnson RK Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743 [TBL] [Abstract][Full Text] [Related]
14. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone. Gutierrez PL; Wilder PJ; Biswal N Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972 [TBL] [Abstract][Full Text] [Related]
15. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate. Ramu A; Fuks Z; Gatt S; Glaubiger D Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032 [TBL] [Abstract][Full Text] [Related]
16. Adriamycin resistance in human tumor cells associated with marked alteration in the regulation of the hexose monophosphate shunt and its response to oxidant stress. Yeh GC; Occhipinti SJ; Cowan KH; Chabner BA; Myers CE Cancer Res; 1987 Nov; 47(22):5994-9. PubMed ID: 3664503 [TBL] [Abstract][Full Text] [Related]
17. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance. Sinha BK; Mimnaugh EG; Rajagopalan S; Myers CE Cancer Res; 1989 Jul; 49(14):3844-8. PubMed ID: 2544260 [TBL] [Abstract][Full Text] [Related]
18. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells. Ganapathi R; Reiter W; Krishan A J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267 [TBL] [Abstract][Full Text] [Related]
19. [Phosphorus-containing metabolites in the cells of anthracycline-resistant strains of leukemia P388]. Shiriaeva OA; Semenova NA; Sibel'dina LA; Goncharova SA; Konovalova NP Eksp Onkol; 1989; 11(4):70-3. PubMed ID: 2759015 [TBL] [Abstract][Full Text] [Related]
20. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists. Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]